Spine

From long-term disc replacement outcomes to outpatient spine case volume, here are four key spine studies Becker's reported on since June 10.

Spine devicemaker FloSpine has secured $1.7 million in seed funding after recently closing on $530,000 in capital, according to a July 8 report from Refresh Miami.

Lumbar spinal fusion procedures are more likely to fail in patients with diabetes, according to a new study from the University of Toledo (Ohio). 

A partnership with Blue Cross Blue Shield has proven beneficial for patient care and finances, Mick Perez-Cruet, MD, said during a panel at the 21st Annual Spine, Orthopedic & Pain Management-Driven ASC + The Future of Spine Conference in Chicago.

In a recent press release, L&K Spine Inc. was proud to announce the successful completion of the 2,000th level implantation of the Expandable Cage, a state-of-the-art spinal implant technology.

Progenitor cells from intervertebral disc tissue were found to be safe for increasing disc volume and reducing pain in lumbar disc degeneration patients, according to a study in the June 2024 issue of the International Journal of Spine Surgery.

Here are 18 spine surgeons and neurosurgeons that have joined new hospitals and health systems that Becker's has reported on through the first six months of 2024:

An international study out of Stanford (Calif.) University found measuring the width of spared spinal cord tissue at an injury site can help predict patient recovery.

Neuralink, Elon Musk's neurotechnology company, canceled its plans for a second brain implant surgery due to the patient's medical condition, Bloomberg reported June 28.

Marko Tomov, MD, will join Casper (Wyo.) Orthopedics starting Aug. 1, according to a July 1 news release shared with Becker's.